论文部分内容阅读
目的观察常规治疗下的充血性心力衰竭(CHF)在联用β受体阻滞剂后的疗效。方法将78例患者随机分成治疗组38例、对照组40例,均给予强心、利尿和血管紧张素转换酶抑制剂治疗,治疗组加用β受体阻滞剂美托洛尔,观察临床疗效及超声心动图参数的变化。结果治疗组显效率81.6%,对照显效率52.5%,2组比较差异有统计学意义(P<0.05);与对照组及治疗4周后比较,LVEF、E/A值、LVSD、LVDD和LAD的差异有统计学意义(P<0.05)。结论在常规治疗的基础上,应用美托洛尔可提高治疗CHF的疗效,其长期应用效果优于短期应用效果。
Objective To observe the curative effect of conventional treatment of congestive heart failure (CHF) in combination with β-blocker. Methods A total of 78 patients were randomly divided into treatment group (38 cases) and control group (40 cases). All patients were treated with cardiotomy, diuretic and angiotensin converting enzyme inhibitors. The treatment group received metoprolol, a beta blocker, Efficacy and echocardiographic parameters changes. Results Compared with control group and 4 weeks after treatment, LVEF, E / A, LVSD, LVDD and LAD were significantly decreased in treatment group (81.6% vs 52.5%, P <0.05) The difference was statistically significant (P <0.05). Conclusion On the basis of routine treatment, the application of metoprolol can improve the curative effect of CHF, its long-term effect is better than that of short-term effect.